References
- Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non- A/non-B in the United States: CDC sentinel county hepatitis study I. Am J Med 1984; 76(1): 69–74
- Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39(RR 2): 1–26
- American Academy of Pediatrics Committee on Infectious Diseases. Universal hepatitis B immunization. Pediatrics 1992;89(4 Pt 2): 795–800
- Franks AL, Berg CJ, Kane MA, et al. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. N Engl J Med 1989: 321(19): 1301–5 [erratum, N Engl J Med 1990;322(4): 280]
- Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991: 40(RR 13): 1–25
- Clarke JA, Hollinger FB, Lewis E, et al. Intradermal inoculation with Heptavax-B: immune response and histologic evaluation of injection sites. JAMA 1989: 262(18): 2567–71
- Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B: United States, 1990–1991. MMWR 1991;40(33): 569–72
- Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315(4): 209–14
- Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321(11): 708–12
- Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262(9): 1201–5